The Treatment of Glabellar Frown Lines
Public ClinicalTrials.gov record NCT02096081. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT02096081
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Merz North America, Inc.
- Industry
- Enrollment
- 250 participants
Conditions and interventions
Conditions
Interventions
- IncobotulinumtoxinA Drug
- OnabotulinumtoxinA Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2014
- Primary completion
- Jul 31, 2014
- Completion
- Oct 31, 2014
- Last update posted
- Oct 18, 2017
2014
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Merz Investigative Site #001099 | Los Angeles | California | 90069 | — |
| Merz Investigative Site #001300 | Sacramento | California | 95819 | — |
| Merz Investigative Site #001299 | Santa Monica | California | 90404 | — |
| Merz Investigative Site #001298 | Washington D.C. | District of Columbia | 20005 | — |
| Merz Investigative Site #001170 | Washington D.C. | District of Columbia | 20037 | — |
| Merz Investigative Site #001101 | Coral Gables | Florida | 33146 | — |
| Merz Investigative Site #001105 | Metairie | Louisiana | 70006 | — |
| Merz Investigative Site #001098 | Chestnut Hill | Massachusetts | 02467 | — |
| Merz Investigative Site #001297 | New York | New York | 10065 | — |
| Merz Investigative Site #001097 | Nashville | Tennessee | 37215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02096081, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 18, 2017 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02096081 live on ClinicalTrials.gov.